COVID-19 associated liver injury: An updated review on the mechanisms and management of risk groups

[1]  Zehuan Liao,et al.  Children with type 1 diabetes in COVID-19 pandemic: Difficulties and solutions , 2022, World Journal of Clinical Pediatrics.

[2]  S. Lucas.  Where does SARS‐CoV‐2 go to in man? , 2022, The Journal of pathology.

[3]  Zehuan Liao,et al.  Management of the COVID-19 Pandemic in Singapore from 2020 to 2021: A Revisit , 2022, Reports.

[4]  L. A. Martínez-Cruz,et al.  The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytes , 2022, Communications Biology.

[5]  Mina Wang,et al.  Gut microbiota and diabetic kidney diseases: Pathogenesis and therapeutic perspectives , 2022, World journal of diabetes.

[6]  Z. Rao,et al.  Nanometer-resolution in situ structure of the SARS-CoV-2 postfusion spike protein , 2021, Proceedings of the National Academy of Sciences.

[7]  Ghada M. Salum,et al.  The Impact of COVID-19 on Liver Injury , 2021, The American Journal of the Medical Sciences.

[8]  M. Cygler,et al.  Disulfide Bonds Play a Critical Role in the Structure and Function of the Receptor-binding Domain of the SARS-CoV-2 Spike Antigen , 2021, Journal of Molecular Biology.

[9]  D. Stuart,et al.  The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants , 2021, Cell Host & Microbe.

[10]  D. Annane,et al.  Corticosteroid treatment in severe patients with SARS-CoV-2 and chronic HBV co-infection: a retrospective multicenter study , 2021, BMC Infectious Diseases.

[11]  Bharat Kumar Reddy Sanapalli,et al.  Imidazoles and benzimidazoles as putative inhibitors of SARS-CoV-2 B.1.1.7 (Alpha) and P.1 (Gamma) variant spike glycoproteins: A computational approach , 2021, Chemical Papers.

[12]  E. Can,et al.  Abnormal liver function tests in pregnant patients with COVID-19 - a retrospective cohort study in a tertiary center. , 2021, Ginekologia polska.

[13]  Mina Wang,et al.  Non-Coding RNA as Biomarkers for Type 2 Diabetes Development and Clinical Management , 2021, Frontiers in Endocrinology.

[14]  H. L. Braz,et al.  Recent advances in SARS-CoV-2 Spike protein and RBD mutations comparison between new variants Alpha (B.1.1.7, United Kingdom), Beta (B.1.351, South Africa), Gamma (P.1, Brazil) and Delta (B.1.617.2, India) , 2021, Journal of Virus Eradication.

[15]  R. Desert,et al.  Well-differentiated liver cancers reveal the potential link between ACE2 dysfunction and metabolic breakdown , 2021, Scientific Reports.

[16]  Chuyao Jin,et al.  Risk of Gestational Diabetes Mellitus in relation to Plasma Concentrations of Fatty Acid-Binding Protein 4: A Nested Case-Control Study in China , 2021, Journal of diabetes research.

[17]  J. Arab,et al.  COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence , 2021, Journal of clinical and translational hepatology.

[18]  S. Guarino,et al.  COVID-19 and pediatric fatty liver disease: Is there interplay? , 2021, World journal of gastroenterology.

[19]  F. Piersigilli,et al.  Pregnancy and viral infections: Mechanisms of fetal damage, diagnosis and prevention of neonatal adverse outcomes from cytomegalovirus to SARS-CoV-2 and Zika virus , 2021, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

[20]  Xu-guang Guo,et al.  Liver injury in COVID-19: clinical features and treatment management , 2021, Virology Journal.

[21]  J. Rappaport,et al.  SARS-CoV-2 beta variant substitutions alter spike glycoprotein receptor binding domain structure and stability , 2021, bioRxiv.

[22]  M. Giacca,et al.  The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets , 2021, Nature Microbiology.

[23]  A. Ng.  Liver Injury in Liver Transplant Patients With COVID-19: A Histopathologic Analysis , 2021, Clinical Gastroenterology and Hepatology.

[24]  H. Cichoż-Lach,et al.  Liver injury in the era of COVID-19 , 2021, World journal of gastroenterology.

[25]  Alexandra J. Lee,et al.  Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure , 2021, ArXiv.

[26]  E. Barnes,et al.  SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question , 2021, The Lancet Gastroenterology & Hepatology.

[27]  S. Kang,et al.  SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells , 2021, Frontiers in Molecular Biosciences.

[28]  Ruoqing Li,et al.  Liver injury in COVID-19 patients with metabolic syndrome-a narrative review. , 2021, Annals of palliative medicine.

[29]  Yuanbo Fu,et al.  Psychological Impact of COVID-19 Cases on Medical Staff of Beijing Xiaotangshan Hospital , 2021, Psychology research and behavior management.

[30]  M. Trauner,et al.  Pathophysiological mechanisms of liver injury in COVID‐19 , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[31]  A. Luciani,et al.  Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area , 2020, JHEP Reports.

[32]  Jinkui Yang,et al.  Angiotensin‐(1‐7), the product of ACE2 ameliorates NAFLD by acting through its receptor Mas to regulate hepatic mitochondrial function and glycolipid metabolism , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  A. Tang,et al.  Liver Injury as a Surrogate for Inflammation and Predictor of Outcomes in COVID‐19 , 2020, Hepatology communications.

[34]  T. Hirano,et al.  How COVID-19 induces cytokine storm with high mortality , 2020, Inflammation and regeneration.

[35]  J. A. Cook,et al.  Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study , 2020, Journal of Hepatology.

[36]  H. Wei,et al.  Oxygen therapy strategies and techniques to treat hypoxia in COVID-19 patients. , 2020, European review for medical and pharmacological sciences.

[37]  M. Wang,et al.  SARS-CoV-2 and COVID-19: How much do we know? , 2020, Acta virologica.

[38]  A. Gasbarrini,et al.  COVID‐19 and hepatic involvement: The liver as a main actor of the pandemic novel , 2020, Scandinavian journal of immunology.

[39]  C. Zheng,et al.  Liver injury in patients with COVID-19: clinical profiles, CT findings, the correlation of the severity with liver injury , 2020, Hepatology International.

[40]  Jian-Gao Fan,et al.  Etiology and management of liver injury in patients with COVID-19 , 2020, World journal of gastroenterology.

[41]  J. A. Cook,et al.  Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study , 2020, The Lancet Gastroenterology & Hepatology.

[42]  Mina Wang,et al.  Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments , 2020, Frontiers in Endocrinology.

[43]  Y. Xin,et al.  ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19 , 2020, Biomedicine & Pharmacotherapy.

[44]  Keith Sigel,et al.  An inflammatory cytokine signature predicts COVID-19 severity and survival , 2020, Nature Medicine.

[45]  Q. Hamid,et al.  Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue , 2020, Archives of Toxicology.

[46]  G. Blanco-Fernández,et al.  Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients , 2020, Journal of Hepatology.

[47]  Wenyu Lin,et al.  COVID-19 induced liver function abnormality associates with age , 2020, Aging.

[48]  Wei Zhang,et al.  Involvement of liver in COVID-19: systematic review and meta-analysis , 2020, Gut.

[49]  Khaled Hossain,et al.  Liver injury in severe COVID-19 infection: current insights and challenges , 2020, Expert review of gastroenterology & hepatology.

[50]  E. Ghigo,et al.  Changes in Weight and Nutritional Habits in Adults with Obesity during the “Lockdown” Period Caused by the COVID-19 Virus Emergency , 2020, Nutrients.

[51]  C. Pelliccia,et al.  The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2 , 2020, European Journal of Clinical Pharmacology.

[52]  P. Galle,et al.  Patterns of liver injury in COVID-19 – a German case series , 2020, United European gastroenterology journal.

[53]  Marcin Krawczyk,et al.  COVID‐19 and non‐alcoholic fatty liver disease: Two intersecting pandemics , 2020, European journal of clinical investigation.

[54]  Vishal Sharma,et al.  Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis , 2020, Hepatology International.

[55]  Xiang Chen,et al.  Characteristics of pregnant COVID-19 patients with liver injury , 2020, Journal of Hepatology.

[56]  Mina Wang,et al.  Diabetes and cancer: Epidemiological and biological links , 2020, World journal of diabetes.

[57]  T. Şahin,et al.  COVID-19 pandemic: Its impact on liver disease and liver transplantation , 2020, World journal of gastroenterology.

[58]  Mina Wang,et al.  Mechanism of Traditional Chinese Medicine in Treating Knee Osteoarthritis , 2020, Journal of pain research.

[59]  E. Verna,et al.  Acute Liver Injury in COVID‐19: Prevalence and Association with Clinical Outcomes in a Large U.S. Cohort , 2020, Hepatology.

[60]  J. Schattenberg,et al.  Liver injury in COVID-19: The current evidence , 2020, United European gastroenterology journal.

[61]  Q. Ye,et al.  Hepatic complications of COVID‐19 and its treatment , 2020, Journal of medical virology.

[62]  G. Mahé,et al.  Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19 , 2020, Clinical Immunology.

[63]  S. Ng,et al.  Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis , 2020, The Lancet Gastroenterology & Hepatology.

[64]  X. Zhao,et al.  The Impact of Coronavirus Disease 2019 (COVID-19) on Liver Injury in China: A Systematic Review and Meta-analysis , 2020, medRxiv.

[65]  Junyan Han,et al.  Effects Of ARBs And ACEIs On Virus Infection, Inflammatory Status And Clinical Outcomes In COVID-19 Patients With Hypertension: A Single Center Retrospective Study. , 2020, Hypertension.

[66]  N. Uriel,et al.  COVID-19 in solid organ transplant recipients: Initial report from the US epicenter , 2020, American Journal of Transplantation.

[67]  F. Tacke,et al.  Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: A By-proxy Society Recommendation Consensus approach , 2020, American Journal of Transplantation.

[68]  J. Qiao,et al.  Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China , 2020, The New England journal of medicine.

[69]  Mario Plebani,et al.  Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis , 2020, Clinical chemistry and laboratory medicine.

[70]  Zhanju Liu,et al.  Clinical Features of COVID-19-Related Liver Functional Abnormality , 2020, Clinical Gastroenterology and Hepatology.

[71]  T. Vanhaecke,et al.  COVID-19 and drug-induced liver injury: a problem of plenty or a petty point? , 2020, Archives of Toxicology.

[72]  Chao Zhang,et al.  Liver injury in COVID-19: management and challenges , 2020, The Lancet Gastroenterology & Hepatology.

[73]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[74]  Shuye Zhang,et al.  Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses , 2020, bioRxiv.

[75]  Z. Zhao,et al.  Structure analysis of the receptor binding of 2019-nCoV , 2020, Biochemical and Biophysical Research Communications.

[76]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[77]  S. Okada,et al.  Clinical Features of Liver Injury Induced by Immune Checkpoint Inhibitors in Japanese Patients , 2019, Canadian journal of gastroenterology & hepatology.

[78]  F. Zoulim,et al.  CD8+T cells from patients with cirrhosis display a phenotype that may contribute to cirrhosis-associated immune dysfunction , 2019, EBioMedicine.

[79]  Ryan Basith Fasih Khan,et al.  From Pre-Diabetes to Diabetes: Diagnosis, Treatments and Translational Research , 2019, Medicina.

[80]  K. Pantopoulos,et al.  Iron homeostasis and oxidative stress: An intimate relationship. , 2019, Biochimica et biophysica acta. Molecular cell research.

[81]  Yongsheng Yu,et al.  STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis , 2018, The Journal of clinical investigation.

[82]  N. Tan,et al.  An aPPARent Functional Consequence in Skeletal Muscle Physiology via Peroxisome Proliferator-Activated Receptors , 2018, International journal of molecular sciences.

[83]  M. Saklayen.  The Global Epidemic of the Metabolic Syndrome , 2018, Current Hypertension Reports.

[84]  H. Jaeschke.  Acetaminophen: Dose-Dependent Drug Hepatotoxicity and Acute Liver Failure in Patients , 2015 .

[85]  H. Jaeschke.  Acetaminophen: Dose-Dependent Drug Hepatotoxicity and Acute Liver Failure in Patients , 2015, Digestive Diseases.

[86]  M. Wabitsch,et al.  HIV Protease Inhibitors Disrupt Lipid Metabolism by Activating Endoplasmic Reticulum Stress and Inhibiting Autophagy Activity in Adipocytes , 2013, PloS one.

[87]  S. López-Briones,et al.  [Cells of innate and adaptive immunity in type 2 diabetes and obesity]. , 2012, Gaceta medica de Mexico.

[88]  A. Burroughs,et al.  Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. , 2010, Gastroenterology.

[89]  P. Hylemon,et al.  Prevention of HIV Protease Inhibitor-Induced Dysregulation of Hepatic Lipid Metabolism by Raltegravir via Endoplasmic Reticulum Stress Signaling Pathways , 2010, Journal of Pharmacology and Experimental Therapeutics.

[90]  J. Tam,et al.  Lipid rafts are involved in SARS-CoV entry into Vero E6 cells , 2008, Biochemical and Biophysical Research Communications.

[91]  D. Adams,et al.  Systemic Viral Infections and Collateral Damage in the Liver , 2006, The American Journal of Pathology.

[92]  M. Gentry,et al.  Pneumococcal vaccine response in cirrhosis and liver transplantation. , 2000, The Journal of infectious diseases.

[93]  Webb,et al.  COVID-19 and liver disease: mechanistic and clinical perspectives , 2021 .

[94]  J. Kielstein,et al.  Obesity-related immunodeficiency in patients with pandemic influenza H1N1. , 2011, The Lancet. Infectious diseases.

[95]  E. Plée-Gautier,et al.  Interactions alcool–xénobiotiques. Rôle du cytochrome P450 2E1 , 2001 .